Φορτώνει......
Hematopoietic stem cell transplantation in the era of engineered cell therapy.
PURPOSE OF REVIEW: Cellular therapy using T cells modified to express chimeric antigen receptors (CAR-T cells) has had striking success in patients that have failed previous treatment for CD19+ B cell non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL) or acute lymphoblastic leukemia (ALL...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Curr Hematol Malig Rep |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6333424/ https://ncbi.nlm.nih.gov/pubmed/30280289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-018-0476-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|